Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)

NCT00644358 ·Status: COMPLETED ·Phase: PHASE3

A Safety, Efficacy and Tolerability Study of SEP-225289

NCT00584974 ·Status: COMPLETED ·Phase: PHASE2

Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?

NCT01856127 ·Status: TERMINATED ·Phase: PHASE4

Safety and Efficacy of Vilazodone in Major Depressive Disorder

NCT01573598 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

NCT00092911 ·Status: COMPLETED ·Phase: PHASE3

Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone

NCT02015546 ·Status: COMPLETED ·Phase: PHASE3

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

NCT03749629 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)

NCT02372799 ·Status: COMPLETED ·Phase: PHASE3

A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder

NCT02436239 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Sexual Functioning of Healthy Adults After Receiving Vilazodone, Paroxetine or Placebo

NCT02097147 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder

NCT03000530 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

NCT00090649 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress

NCT02498392 ·Status: COMPLETED ·Phase: PHASE2

Study Of GW679769 In Major Depressive Disorder

NCT00102492 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD

NCT06236880 ·Status: RECRUITING ·Phase: PHASE2

Study for Evaluating Different Methods of Measuring Depression Treatment Response

NCT00406952 ·Status: COMPLETED ·Phase: NA

Sertraline vs. Venlafaxine XR

NCT00179283 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

NCT00063206 ·Status: COMPLETED ·Phase: PHASE3

Study of NSI-189 for Major Depressive Disorder

NCT02695472 ·Status: UNKNOWN ·Phase: PHASE2

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

NCT00048204 ·Status: COMPLETED ·Phase: PHASE2

A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder

NCT00880048 ·Status: TERMINATED ·Phase: PHASE2

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

NCT00075257 ·Status: COMPLETED ·Phase: PHASE3

A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression

NCT03559192 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression

NCT00177528 ·Status: COMPLETED ·Phase: PHASE4

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

NCT00191061 ·Status: COMPLETED ·Phase: PHASE4